組織工程市場：依移植類型、材料類型、應用和地區分類

Tissue Engineering Market, By Graft Type, By Material Type, By Application, By Geography

出版日期: 2026年04月01日 | 出版商:

Coherent Market Insights | 英文 154 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

組織工程市場預計2026年達到146.2億美元，預計2033年將達到329.3億美元。預計從2026年到2033年，其複合年成長率將達到12.3%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	146.2億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	12.30%	2033年市場規模預測：	329.3億美元

組織工程是一門交叉學科，它運用工程學和生命科學的原理，開發生物替代物，用於修復、維持或改善組織功能。這包括將人體細胞接種到被稱為「支架」的生物惰性材料上，這些支架可以支持新組織的生長。組織工程市場涉及用於修復和替代受損組織和器官的各種產品的研發和生產。慢性病盛行率的上升、老年人口中肌肉骨骼疾病患者的增加以及技術的進步是推動該市場需求的主要因素。然而，組織工程產品的高成本以及與生物材料和幹細胞使用相關的倫理問題限制了市場的擴張。

市場動態：

全球組織工程市場的發展主要受癌症和心血管疾病等慢性疾病發病率上升的驅動，這些疾病對組織替代療法的需求日益成長。另一個重要的市場促進因素是全球老年人口的快速成長，他們更容易罹患整形外科疾病。世界衛生組織（WHO）預測，2015年至2050年間，全球60歲及以上人口的比例預計將從12%成長至22%，幾乎翻倍。此外，再生醫學領域的持續技術進步推動了基於幹細胞、可生物分解支架和基因治療技術的新型組織工程產品的開發，從而拓展了組織工程療法的應用範圍。然而，組織工程手術的高成本、生物材料的加工成本以及與幹細胞研究相關的監管問題仍然是市場發展的主要障礙。熟練複雜組織工程手術的專業人員短缺也阻礙了市場成長。儘管如此，目前致力於降低支架生物材料製造成本以及採用個人化醫療方法的研發工作為相關人員帶來了充滿希望的機會。

本研究的主要特點：

本研究確定了各細分市場的潛在收入成長機會，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球組織工程市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
本研究涵蓋的主要公司包括 Acelity LP Inc.、AbbVie Inc.、B. Braun SE、BioMimetic Therapeutics、Bio Tissue Technologies、CR Bard、International Stem Cell、Integra Lifesciences、Organogenesis Inc.、Osiris Therapeutics、RTI Surgical, Inc.、Tissue Rerapyt Group。
透過利用本報告中提出的見解，各公司的行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球組織工程市場的目標客戶群包括產業內的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球組織工程市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

公司簡介
- Acelity LP Inc.
- AbbVie Inc.
- B. Braun SE
- BioMimetic Therapeutics
- Bio Tissue Technologies
- CR Bard
- International Stem Cell
- Integra Lifesciences
- Organogenesis Inc.
- Osiris Therapeutics
- RTI surgical, Inc.
- Tissue Regenix Group Plc.
- Zimmer Biomet

第9章分析師觀點

機會分析
分析師意見
Coherent Opportunity Map

第10章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI2217

Tissue Engineering Market is estimated to be valued at USD 14.62 Bn in 2026 and is expected to reach USD 32.93 Bn by 2033, growing at a compound annual growth rate (CAGR) of 12.3% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 14.62 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	12.30%	2033 Value Projection:	USD 32.93 Bn

Tissue engineering is an interdisciplinary field that applies principles of engineering and life sciences towards developing biological substitutes to restore, maintain, or improve tissue function. It involves seeding human cells onto biologically inert materials called scaffolds that can support new tissue growth. The tissue engineering market involves the research, development, and manufacturing of various products used for repairing or replacing damaged tissues and organs. Rising prevalence of chronic diseases, growth in geriatric population suffering from musculoskeletal disorders, and technological advancements are the major factors fueling demand in this market. However, high costs associated with tissue engineering products and ethical issues related to the use of biomaterials and stem cells limits market expansion.

Market Dynamics:

The global tissue engineering market is driven by the increasing incidence of chronic diseases such as cancer and cardiovascular diseases that generate high demand for tissue replacement therapies. Rapid growth in geriatric population worldwide who are highly prone to orthopedic conditions is another key market driver. According to World Health Organization, the proportion of world's population over 60 years will nearly double from 12% to 22% between 2015 and 2050. Furthermore, continuous technological advancements in the field of regenerative medicine has enabled development of novel tissue engineered products based on stem cells, biodegradable scaffolds, and gene therapy techniques. This has expanded applications of tissue engineering therapy. However, high costs of tissue engineering procedures, biomaterial processing and regulatory issues pertaining to stem cell research act as major barriers to the market. Lack of skilled professionals to perform complex tissue engineering surgeries also challenges market growth. Nonetheless, ongoing R&D focused on lowering manufacturing costs of scaffold biomaterials and adoption of personalized medicine approach presents lucrative opportunities for stakeholders.

Key Features of the Study:

It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global tissue engineering market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes Acelity L.P. Inc., AbbVie Inc., B. Braun SE, BioMimetic Therapeutics, Bio Tissue Technologies, C. R. Bard, International Stem Cell, Integra Lifesciences, Organogenesis Inc., Osiris Therapeutics, RTI surgical, Inc., Tissue Regenix Group Plc., and Zimmer Biomet.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global tissue engineering market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global tissue engineering market.

Detailed Segmentation-

By Graft Type (Revenue, USD Bn, 2021 - 2033)
Allografts
Autografts
Xenografts
By Material Type (Revenue, USD Bn, 2021 - 2033)
Synthetic
Biological
Others
By Application (Revenue, USD Bn, 2021 - 2033)
Dermal
Orthopedic
Dental
Neurology
Others
By Region (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles:
Acelity L.P. Inc.
AbbVie Inc.
Braun SE
BioMimetic Therapeutics
Bio Tissue Technologies
C.R. Bard
International Stem Cell
Integra Lifesciences
Organogenesis Inc.
Osiris Therapeutics
RTI surgical, Inc.
Tissue Regenix Group Plc.
Zimmer Biomet

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Graft Type
- Market Snapshot, By Material Type
- Market Snapshot, By Application
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Tissue Engineering Market, By Graft Type, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Allografts
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Autografts
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Xenografts
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Tissue Engineering Market, By Material Type, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Synthetic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Biological
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Tissue Engineering Market, By Application, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Dermal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Orthopedic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Dental
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Neurology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Tissue Engineering Market, By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Graft Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Graft Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Graft Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Graft Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Graft Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Graft Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Acelity L.P. Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- AbbVie Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- B. Braun SE
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- BioMimetic Therapeutics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bio Tissue Technologies
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- C. R. Bard
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- International Stem Cell
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Integra Lifesciences
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Organogenesis Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Osiris Therapeutics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- RTI surgical, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Tissue Regenix Group Plc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Zimmer Biomet
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies